Drug Approval Debate
A thought-provoking discussion unfolds around the complexities of drug approval processes and their impact on innovation. One perspective argues that higher standards could lead to more focused research and development, while the other suggests that current reimbursement systems incentivize the creation of marginal drugs. The conversation delves into the biological constraints of drug discovery and the societal choices that shape healthcare as a right.In this clip
From this podcast
EconTalk
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Related Questions